Herbalife Ltd. has announced its financial results for the third quarter of 2026, revealing a net sales growth of 6.0% compared to the same period last year. This growth marks the fifth consecutive quarter of expansion for the company, showcasing its resilience in a competitive market.

According to the filing dated November 2, 2026, Herbalife reported net sales of $1.35 billion for the quarter ending September 30, 2026. The company attributed this growth to ongoing transformation efforts and strong operational performance.

Company Background

Herbalife Ltd. operates in the wholesale-drugs, proprietaries, and druggists' sundries sector, classified under SIC code 5122. The company trades on the New York Stock Exchange under the ticker symbol HLF. Herbalife has a history of providing nutritional products and health supplements, and it has been publicly traded since its inception.

What the Filing Says

The filing indicates that Herbalife's net income attributable to the company was $58.8 million, with a net income margin of 4.4%. Adjusted net income was reported at $68.5 million, reflecting a margin of 5.1%. The adjusted EBITDA stood at $182.4 million, with an adjusted EBITDA margin of 13.5%, which is an increase of 70 basis points year-over-year.

“Net sales of $1.35 billion, up 6.0% vs. Q3’25, underscores the progress of our transformation,” the company stated in its press release.

Impact

This financial performance may influence various stakeholders, including investors, analysts, and competitors in the wholesale-drug industry. Herbalife's positive results could set a benchmark for other companies in the sector, prompting them to evaluate their strategies and operational efficiencies.

What's Next

The filing does not specify what happens next for Herbalife. However, the company is expected to continue its focus on growth and profitability as it prepares for future quarters.